Cargando…
Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer
Ovarian cancer (OC) is the most lethal gynecological malignancy, with a low 5-year survival rate. Most patients with ovarian cancer are diagnosed in late-stages. A rising number of non-coding RNAs (ncRNAs) have been found to act as key regulators of gene expression by applying novel high-thought met...
Autores principales: | Shao, Yang, Li, Hui, Du, Ran, Meng, Jiao, Yang, Gong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995945/ https://www.ncbi.nlm.nih.gov/pubmed/29896281 http://dx.doi.org/10.7150/jca.24550 |
Ejemplares similares
-
Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
por: Abildgaard, Cecilie, et al.
Publicado: (2020) -
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
por: Zhang, Hai-Bo, et al.
Publicado: (2023) -
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
por: Lan, Hua, et al.
Publicado: (2021) -
Long non-coding RNAs in ovarian cancer
por: Zhan, Lei, et al.
Publicado: (2018) -
The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
por: Li, Gaofeng, et al.
Publicado: (2021)